Trial site
New Orleans
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- High blood pressure4 trials
- Chronic kidney disease1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Metastatic breast cancer1 trial
- Prostate cancer1 trial
- Sarcoidosis1 trial
- Phase
- Phase 24 trials
- Phase 33 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Alnylam Pharmaceuticals5 trials
- Priovant Therapeutics, Inc.2 trials
- Arvinas Inc.1 trial
- Olema Pharmaceuticals, Inc.1 trial
Running trials
Recruiting
Recruiting
A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis
Active, not recruiting
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
Active, not recruiting
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Sarcoidosis1 recruiting
Closed trials
Completed
Completed
A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis
Completed
Completed
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
Completed
Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer
Site data: ClinicalTrials.govUpdated 18 Nov 2026